Hospital Universitari de Bellvitge -ko ikertzaileekin lankidetzan egindako argitalpenak (20)

2024

  1. Dilated Cardiomyopathy With Concomitant Salt-Losing Renal Tubulopathy Caused by Heterozygous RRAGD Gene Variant

    Circulation: Genomic and Precision Medicine, Vol. 17, Núm. 2, pp. E004336

  2. Improving the Access of Highly Sensitized Patients to Kidney Transplantation From Deceased Donors: The Spanish PATHI Program With Allocation Based on the Virtual Crossmatch

    Transplantation, Vol. 108, Núm. 3, pp. 787-801

  3. Toward a Fair Adjusted Analysis of Kidney Graft Survival

    Transplantation

2023

  1. Erratum to “Recommendations for living donor kidney transplantation” (NEFROLOGIA (English Edition) (2022) 42(S2) (1–4), (S2013251422001444), (10.1016/j.nefroe.2022.01.009))

    Nefrologia

  2. Erratum to “Recommendations for living donor kidney transplantation” (NEFROLOGÍA (2022) 42(S2) (129–132), (S0211699522000133), (10.1016/j.nefro.2022.01.007))

    Nefrologia

  3. Post-transplant diabetes mellitus and renal cell cancer after renal transplantation

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 38, Núm. 6, pp. 1552-1559

  4. Treatment and long-term outcome in primary nephrogenic diabetes insipidus

    Nephrology Dialysis Transplantation, Vol. 38, Núm. 10, pp. 2120-2130

2022

  1. Induction immunosuppression and outcome in kidney transplant recipients with early COVID-19 after transplantation

    Clinical Kidney Journal, Vol. 15, Núm. 11, pp. 2039-2045

  2. Live donor kidney transplantation. Situation analysis and roadmap

    Nefrologia, Vol. 42, Núm. 1, pp. 85-93

  3. Recommendations for living donor kidney transplantation

    Nefrologia, Vol. 42, pp. 5-132

2021

  1. Predictors of severe COVID-19 in kidney transplant recipients in the different epidemic waves: Analysis of the Spanish Registry

    American Journal of Transplantation, Vol. 21, Núm. 7, pp. 2573-2582

  2. Use and Safety of Remdesivir in Kidney Transplant Recipients With COVID-19

    Kidney International Reports, Vol. 6, Núm. 9, pp. 2305-2315

2020

  1. COVID-19–related Mortality During the First 60 Days After Kidney Transplantation

    European Urology

  2. Respiratory and Gastrointestinal COVID-19 Phenotypes in Kidney Transplant Recipients

    Transplantation, Vol. 104, Núm. 11, pp. 2225-2233

  3. Use of tocilizumab in kidney transplant recipients with COVID-19

    American Journal of Transplantation, Vol. 20, Núm. 11, pp. 3182-3190

2019

  1. Kidney transplant from controlled donors following circulatory death: Results from the GEODAS-3 multicentre study

    Nefrologia, Vol. 39, Núm. 2, pp. 151-159

2017

  1. Rituximab for Steroid-Dependent or Frequently Relapsing Idiopathic Nephrotic Syndrome in Adults: A Retrospective, Multicenter Study in Spain

    BioDrugs, Vol. 31, Núm. 3, pp. 239-249

2013

  1. Kidney transplantation group of the Spanish society of nephrology

    Nefrologia

2003

  1. Clinical experience with a new bicarbonate (25 mmol/L)/lactate (10 mmol/L) peritoneal dialysis solution

    Peritoneal Dialysis International, Vol. 23, Núm. 2, pp. 138-145

  2. Long-tern efficacy of hyperuricaemia treatment in renal transplant patients

    Nephrology Dialysis Transplantation, Vol. 18, Núm. 3, pp. 603-606